202
2.
El-Amm JM, Gruber SA, 2009. The significance of subclinical rejection.
Clin Transplant 23(2):150-156.
3.
Venetz JP, Pascual M, 2012. Rejets aigus. In: Legendre, C. ed. La
Transplantation Rénale. Paris: Médecine Sciences Publications Lavoisier:
449-464.
4.
Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, et al, 2010.
Banff '09 meeting report: antibody mediated graft deterioration and
implementation of Banff working groups
. Am J Transplant 10(3):464-471.
5.
Glotz D, Antoine C, Julia P, Pegaz-Fiornet B, Duboust A, Boudjeltia S, et al,
2004. Intravenous immunoglobulins and transplantation
for patients with
anti-HLA antibodies.
Transpl Int 17(1):1-8.
6.
Glotz D, 2012. Immunoglobulines polyvalentes intraveineuses. In: Legendre,
C., ed.
La Transplantation Rénale. Paris: Médecine Sciences Publications
Lavoisier: 412-420.
7.
Nishio-Lucar A, Balogun RA, Sanoff S, 2013. Therapeutic apheresis in
kidney transplantation: a review of renal transplant immunobiology and
current interventions with apheresis medicine.
J Clin Apher 28(1):56-63.
8.
Kaplan AA, 2013. Therapeutic plasma exchange: a technical and operational
review.
J Clin Apher 28(1):3-10.
9.
Kỷ Yếu Công Trình Ghép Thận Bệnh Viện Chợ Rẫy 1992-2010, Nhà xuất
bản Y Học, chi nhánh thành phố Hồ Chí minh, 2010